Is virotherapy a good idea?
In recent years, oncolytic virotherapy has emerged as a promising anticancer therapy. Oncolytic viruses destroy cancer cells, without damaging normal tissues, through virus self-replication and antitumor immunity responses, showing great potential for cancer treatment.
What viruses are used in virotherapy?
Promising viruses for mesothelioma virotherapy include modified versions of vaccinia, measles, adenovirus, herpes simplex and Newcastle disease virus. All of these approaches have been studied in clinical trials, though none is approved for widespread clinical use yet.
What is the purpose of oncolytic virotherapy?
Abstract. Oncolytic virotherapy is a new modality of cancer treatment which uses competent replicating viruses to destroy cancer cells. This field progressed from earlier observations of accidental viral infections causing remission in many malignancies to virus drugs targeting and killing cancer cells.
Do oncolytic viruses work?
Oncolytic viruses have long been viewed as tools for directly killing cancer cells. But a growing body of research suggests that some oncolytic viruses may work—at least in part—by triggering an immune response in the body against the cancer.
What virus was used to treat myeloma and how did it work?
Pichiorri was involved in the first human trial of reovirus for multiple myeloma to establish the virus’s safety as a therapy, and is now working on two other phase I trials. At her centre, researchers are also studying the potential of herpes simplex virus 1, which causes cold sores, to treat multiple myeloma.
What is an example of oncolytic virus therapy currently being researched or used in a clinical trial?
There is currently one oncolytic virus therapy approved by the FDA for the treatment of cancer: T-VEC (Imlygic®): a modified herpes simplex virus (HSV) that infects tumor cells and promotes their destruction; approved for subsets of patients with melanoma.
What is virus therapy?
Virotherapy is a treatment using biotechnology to convert viruses into therapeutic agents by reprogramming viruses to treat diseases. There are three main branches of virotherapy: anti-cancer oncolytic viruses, viral vectors for gene therapy and viral immunotherapy.
When was virotherapy invented?
The potential use of echovirus as an oncolytic virus to treat cancer was discovered by Latvian scientist Aina Muceniece in the 1960s and 1970s.
What is virotherapy and how does it work?
Virotherapy and other gene-therapeutic approaches represent a novel class of targeted anticancer agents that is distinct from traditional treatment modalities. The initial focus of this field was to invent and test new agents that kill cancer cells selectively, based on the genetic lesions that cause this disease.
What is oncolytic virotherapy?
Some viruses prefer to attack cancerous tissues rather than healthy ones, and oncolytic virotherapy takes advantage of this fact. Anticancer viruses not only kill off tumor cells but also alert the host immune system to a cancer’s presence.
Can virotherapy be injected directly into the tumor bed?
Some virotherapies can be injected directly into a tumor bed, making delivery a breeze. But many cancers are difficult to reach with a needle, or they might be scattered throughout the body. “This delivery problem is a major challenge,” McFadden said.
How is modern genetic engineering used in virotherapy?
With the help of modern genetic engineering, researchers now strive to build the best oncolytic virus they can and then match the virus with its cancerous archnemesis. The field of virotherapy has significantly advanced in the past few decades, but the research remains difficult.